美托洛爾+曲美他嗪對(duì)冠心病心衰患者治療效果評(píng)價(jià)

打開(kāi)文本圖片集

【摘要】目的：分析在冠心病心力衰竭患者治療過(guò)程中使用美托洛爾與曲美他嗪進(jìn)行聯(lián)合治療的作用。方法：在2018年1月—2021年1月期間醫(yī)院收治的冠心病心力衰竭患者中選取72例分兩組，對(duì)照組給予美托洛爾治療，研究組給予美托洛爾與曲美他嗪聯(lián)合治療，對(duì)比兩種治療方式的作用。結(jié)果：研究組治療有效率（94.44%）高于對(duì)照組（77.78%）（P

【關(guān)鍵詞】冠心?。恍牧λソ?；美托洛爾；曲美他嗪

Evaluation of the therapeutic effect of metoprolol combined with trimetazidine on coronary heart disease and heart failure

LI Jing Xinjiang Production and Construction Corps 7th Division 131st Regiment Hospital， Kuitun， Xinjiang 833200， China

【Abstract】Objective： To analyze the effect of combined therapy with metoprolol and trimetazidine in the treatment of patients with coronary heart disease and heart failure. Methods： From January 2018 to January 2021， 72 patients with coronary heart disease and heart failure admitted to the hospital were selected and divided into two groups. The control group was given metoprolol treatment， and the study group was given the combined treatment of metoprolol and trimetazidine， and the effects of the two treatment methods were compared. Results： The effective rate of treatment in the study group （94.44%） was higher than that in the control group （77.78%） （P

【Key Words】Coronary heart disease； Hheart failure； Metoprolol； trimetazidine

相關(guān)數(shù)據(jù)顯示，作為內(nèi)科常見(jiàn)問(wèn)題之一，冠心病往往不利于患者心臟功能的合理維系，繼而對(duì)患者健康造成了極為不利的影響[1]。（剩余4368字）